A Test-Negative Case-Control Study to Evaluate the Effectiveness of V116, CAPVAXIVETM Against Pneumococcal Pneumonia in Older Adults
Clinical Trial Grant
Awarded By
Merck Sharp & Dohme LLC
Start Date
April 1, 2026
End Date
April 20, 2036
Awarded By
Merck Sharp & Dohme LLC
Start Date
April 1, 2026
End Date
April 20, 2036